Sunisam 50 Mg Sunitinib

Name: Sunisam 50 Mg Sunitinib
Brand: Maheshwari Medical Agency
Price: 1100 INR
Availability: InStock

Price 1100 INR/ Strip

Get a Price/Quote

MOQ : 4 Strips

Sunisam 50 Mg Sunitinib Specification

Dosage Form
Capsulas

Indication
Renal cell carcinoma, Gastrointestinal stromal tumor (GIST), Pancreatic neuroendocrine tumors

Origin
India

Salt Composition
Sunitinib Malate 50 mg

Feature
Oral multi-targeted receptor tyrosine kinase inhibitor

Ingredients
Other

Application
Anticancer medication

Physical Color/Texture
Yellow powder-filled hard gelatin capsules

Storage Instructions
Keep dry & cool place

Shelf Life
24 months

Regulatory Status
Approved Rx

Manufactured By
Samarth Life Sciences Pvt. Ltd.

Marketed By
Sunisam

Therapeutic Class
Antineoplastic Agents

Strength
50 mg per capsule

Prescription/Non Prescription
Prescription only

Country of Import
India

Warning/Precaution
To be used under medical supervision

Packaging Size
28 capsules per box

Route of Administration
Oral

Contraindications
Known hypersensitivity to sunitinib or any component of the formulation

Sunisam 50 Mg Sunitinib Trade Information

Minimum Order Quantity
4 Strips

Supply Ability
1000 Strips Per Month

Delivery Time
7 Days

About Sunisam 50 Mg Sunitinib

Access the brilliant capabilities of Sunisam 50 Mg Sunitinib capsules, a dazzling antineoplastic agent designed for valiant management of renal cell carcinoma, gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors. Manufactured by Samarth Life Sciences Pvt. Ltd. in India and marketed by Sunisam, each box contains 28 yellow, powder-filled hard gelatin capsules containing 50 mg sunitinib malate. Approved for prescription-only use, Sunisam offers the assurance of stringent regulatory standards. Buy or order today through licensed distributors and suppliers. For best results, use strictly under professional supervision. Store in a cool, dry place to maintain efficacy.

Key Features & Application: Sunisam 50 Mg Sunitinib

Sunisam 50 Mg Sunitinib is an orally administered multi-targeted receptor tyrosine kinase inhibitor, indicated for various cancers such as renal cell carcinoma, GIST, and pancreatic neuroendocrine tumors. Designed for use by medical professionals and patients under strict medical guidance, Sunisam's application is straightforward, thanks to its capsule form. Its innovative action targets cancer pathways, delivering exceptional support in oncology care. The medication is primarily used in clinics, hospitals, and specialized medical centers.

Domestic Market, Certification, and Logistics: Sunisam 50 Mg Sunitinib

Sunisam 50 Mg Sunitinib commands significant market value in India, serving trusted healthcare institutions and pharmacies nationwide. Goods transport is efficiently managed to ensure the product's integrity from manufacturer to end-user, adhering to regulatory compliance. Certified for prescription-based distribution, samples are provided based on formal policy requirements. The handover process prioritizes safe, verified delivery backed by documentation, ensuring only authorized medical professionals access this critical anticancer medication.

FAQ's of Sunisam 50 Mg Sunitinib:

Q: How should Sunisam 50 Mg Sunitinib be administered?

A: Sunisam 50 Mg Sunitinib is intended for oral use and should be taken exactly as prescribed by your oncologist or qualified healthcare provider. Do not alter the dosage or discontinue use unless directed.

Q: What are the primary benefits of using Sunisam 50 Mg Sunitinib?

A: Sunisam 50 Mg Sunitinib is designed to inhibit cancer cell growth in conditions such as renal cell carcinoma, GIST, and pancreatic neuroendocrine tumors, improving treatment outcomes when used under proper medical supervision.

Q: When should Sunisam 50 Mg Sunitinib not be used?

A: Sunisam 50 Mg Sunitinib should not be used if you have a known hypersensitivity to sunitinib or any of its components. Always inform your doctor of allergies or adverse reactions prior to starting therapy.

Q: What precautions must be taken during the usage of Sunisam 50 Mg Sunitinib?

A: This medication should be used strictly under medical supervision, with regular follow-up for monitoring potential side effects. Store the capsules in a dry, cool environment and keep them out of reach of children.

Q: Where is Sunisam 50 Mg Sunitinib manufactured and marketed?

A: Sunisam 50 Mg Sunitinib is manufactured by Samarth Life Sciences Pvt. Ltd. and marketed by Sunisam, both based in India, and is available via authorized distributors, suppliers, and traders throughout the country.

Tell us about your requirement